Affiliation: Centre Hospitalier Universitaire Vaudois
- Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron diseaseMichel Beauverd
Service de Soins Palliatifs, CentreHospitalierUniversitaire Vaudois CHUV, Lausanne, Switzerland
Cochrane Database Syst Rev 11:CD002064. 2012..Recombinant human insulin-like growth factor I (rhIGF-I) is a possible disease modifying therapy for amyotrophic lateral sclerosis (ALS, which is also known as motor neuron disease (MND))...